Biochem/physiol Actions
Melitracen is a tricyclic antidepressant (TCA) that likely exerts its in vivo efficacy similarly as imipramine and amitriptyline by inhibiting serotonin-norepinephrine reuptake.
This product has met the following criteria to qualify for the following awards: